Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CaPSURE database

Autor: Mark S. Litwin, Scott C. Flanders, Warren H. Schonfeld, Peter R. Carroll, Curtis J. Henke, David F. Penson, Karen L. Warolin
Rok vydání: 2001
Předmět:
Zdroj: Urology. 57:499-503
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(00)01033-5
Popis: Objectives. To determine the relationship among the initial choice of therapy, stage at presentation, and first-year treatment costs in men with newly diagnosed localized prostate cancer. Methods. First-year resource use and clinical data were collected for 235 subjects with newly diagnosed localized prostate cancer. The costs were estimated from the standard Medicare payment schedules. The relationship among the initial therapy, stage at presentation, and overall cost was examined for the entire cohort and in the subgroup of patients who underwent radical prostatectomy. In addition, the inpatient, outpatient, and medication cost components were evaluated separately to determine what influenced the changes in cost by stage. Results. The mean first-year cost of treating localized prostate cancer in CaPSURE was $6375. When broken down by stage, the mean first-year cost for patients with Stage T1c was $5731, with T2a/b was $6426, and with Stage T2c was $6810 (P = 0.059). The initial treatment choice was significantly associated with the total first-year costs (P
Databáze: OpenAIRE